FOLH1 and neoplasm: When advanced stages of disease are reached and as castration-resistance develops, a common phenomenon detected by PSMA PET/CT is a decrease in PSMA expression, which signals that tumor cells are becoming dedifferentiated or going through neuroendocrine differentiation, which might occur in up to 25% of patients [44].